This Friday, March 2nd, Michael Bird, Senior Project Executive for Gilbane Building Company will host his first meeting as the Corporate Walk Chair of The Leukemia and Lymphoma Society’s (LLS) West Palm Beach Light The Night®. Light the Night is LLS’s annual fundraising campaign to find cures and provide access to treatments for blood cancer patients. The Corporate Walk Chair will lead the effort in accelerating corporate support and driving revenue growth for Light The Night to support LLS’s ultimate goal of creating a world without blood cancers
Light The Night is a fundraising campaign benefiting LLS and their funding of research to find blood cancer cures. Coming together for a common goal, friends, family and co-workers form fundraising walk teams. Millions of consumers also help by donating at retail outlets. Culminating in inspiration and memorable evening walks every fall, participants in 150 communities across North America join together carrying illuminated lanterns to take steps to end cancer – white for survivors, red for supporters and gold in memory of loved ones lost to cancer.
“It is an honor and a privilege to serve as the Corporate Walk Chair this year. I look forward to encouraging local business and corporations throughout the area to join me in supporting the mission of LLS by not only participating in the walk, but also by getting involved now and throughout the year”. Said Bird, a Non-Hodgkins Lymphoma survivor and LLS’s West Palm Beach Light The Night Chair. “Together, we can take the steps to end cancer.”
This year, the event will be held on Friday, November 9, 2018 at the Fitteam Ballpark of the Palm Beaches.
“When a loved one hears the words “you have cancer,” it is one of the darkest moments in your life,” said Pam Payne, LLS Executive Director. “At Light The Night, it is our aim to bring light to the darkness of cancer through research and cures, and reinforce the urgent need to raise more funds to fight cancer.”
LLS is the world’s largest voluntary health agency dedicated to finding cures for leukemia, lymphoma, myeloma and other blood cancers. Through its efforts it has invested more than $1 billion in cutting-edge research to advance therapies. Thanks to research, survival rates for patients with many blood cancers have doubled, tripled and even quadrupled since the early 1960s. Yet, despite these advances, about one third of patients with blood cancer still do not survive even five years after their diagnosis.
To become part of the LTN Family, contact the Palm Beach Area Chapter at 561-623-4560, or www.lightthenight.org/pb.